Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D01TFO
|
||||
Former ID |
DNC004033
|
||||
Drug Name |
Z-Ala-Leu-lle-Agly-Ile-Val-OMe
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [526417] | ||
Structure |
Download2D MOL |
||||
Formula |
C36H59N7O9
|
||||
Canonical SMILES |
CCC(C)C(C(=O)NNC(=O)NC(C(C)CC)C(=O)NC(C(C)C)C(=O)OC)NC(<br />=O)C(CC(C)C)NC(=O)C(C)NC(=O)OCC1=CC=CC=C1
|
||||
InChI |
1S/C36H59N7O9/c1-11-22(7)28(32(46)39-27(21(5)6)34(48)51-10)41-35(49)43-42-33(47)29(23(8)12-2)40-31(45)26(18-20(3)4)38-30(44)24(9)37-36(50)52-19-25-16-14-13-15-17-25/h13-17,20-24,26-29H,11-12,18-19H2,1-10H3,(H,37,50)(H,38,44)(H,39,46)(H,40,45)(H,42,47)(H2,41,43,49)
|
||||
InChIKey |
HGMOIJOFHZHWKH-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cathepsin B | Target Info | Inhibitor | [526417] | |
Cathepsin K | Target Info | Inhibitor | [526417] | ||
Reactome | Collagen degradation | ||||
Trafficking and processing of endosomal TLR | |||||
Assembly of collagen fibrils and other multimeric structures | |||||
MHC class II antigen presentationR-HSA-1442490:Collagen degradation | |||||
Degradation of the extracellular matrix | |||||
Activation of Matrix Metalloproteinases | |||||
MHC class II antigen presentation | |||||
WikiPathways | RANKL/RANK Signaling Pathway | ||||
Osteoclast Signaling | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.